Comparison between Covishield and Covaxin

Covishield and Covaxin What do we know about Indian vaccines?

Preliminary data from its 3rd phase of clinical trials indicate that the domestically produced and government-backed Covaxin in India has an efficacy rate of 81%. The use of the Oxford-AstraZeneca vaccine, also known as Covishield, has also been approved in India.